The Russian military assault on Ukraine has profoundly shocked knowledge institutions in the Netherlands, as represented by Universities of the Netherlands, the Netherlands Association of Universities of Applied Sciences, the Royal Netherlands Academy of Arts and Sciences, the Dutch Research Council, the Dutch Federation of University Medical Centres and The Young Academy. This is a direct assault on liberty and democracy, which are the fundamental values undergirding academic freedom and cooperation.
Toxys will immediately commercialize and develop further the in vitro reporter technology for mechanistic toxicity testing to improve the human safety assessment of novel medicines, chemicals and cosmetic ingredients.
LEIDEN, The Netherlands, January 28, 2021 / B3C newswire / Toxys, Leiden University and Leiden University Medical Center have agreed immediately to commercialize and also develop further the ToxProfiler technology invented at the two institutions. ToxProfiler allows for rapid toxicity hazard identification of novel and existing drugs, chemicals, and other substances. Furthermore, ToxProfiler has the unique ability to provide detailed and quantitative information about the mode-of-action of such toxic substances. This new technology thereby enormously enlarges the portfolio of toxicity testing that Toxys can make available to the world, complementing the existing genotoxicity and repro-toxicity testing platforms of Toxys.